412 related articles for article (PubMed ID: 33172464)
41. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Mahaffey KW; Tonev ST; Spinler SA; Levine GN; Gallo R; Ducas J; Goodman SG; Antman EM; Becker RC; Langer A; White HD; Aylward PE; Col JJ; Ferguson JJ; Califf RM;
Int J Cardiol; 2010 Mar; 139(2):123-33. PubMed ID: 19012977
[TBL] [Abstract][Full Text] [Related]
42. Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry.
Colombo MG; Meisinger C; Amann U; Heier M; von Scheidt W; Kuch B; Peters A; Kirchberger I
Cardiovasc Diabetol; 2015 Feb; 14():24. PubMed ID: 25885918
[TBL] [Abstract][Full Text] [Related]
43. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
[TBL] [Abstract][Full Text] [Related]
44. Association of Body Mass Index with Risk of Major Adverse Cardiovascular Events and Mortality in People with Diabetes.
Lee DH; Ha KH; Kim HC; Kim DJ
J Obes Metab Syndr; 2018 Mar; 27(1):61-70. PubMed ID: 31089542
[TBL] [Abstract][Full Text] [Related]
45. Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials.
Faggioni M; Baber U; Afshar AE; Giustino G; Sartori S; Sorrentino S; Steg PG; Stefanini GG; Windecker S; Leon MB; Stone GW; Wijns W; Serruys PW; Valgimigli M; Camenzind E; Weisz G; Smits PC; Kandzari DE; Galatius S; Von Birgelen C; Jeger RV; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Dangas GD; Morice MC; Mehran R
JACC Cardiovasc Interv; 2018 Jan; 11(1):68-76. PubMed ID: 29248412
[TBL] [Abstract][Full Text] [Related]
46. Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention.
Cai A; Dillon C; Hillegass WB; Beasley M; Brott BC; Bittner VA; Perry GJ; Halade GV; Prabhu SD; Limdi NA
J Am Heart Assoc; 2019 Nov; 8(22):e012874. PubMed ID: 31701784
[TBL] [Abstract][Full Text] [Related]
47. Clinical Implication of 'Obesity Paradox' in Elderly Patients With Acute Myocardial Infarction.
Kim HT; Jung SY; Nam JH; Lee JH; Lee CH; Son JW; Kim U; Park JS; Shin DG; Her SH; Chang KY; Ahn TH; Jeong MH; Rha SW; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Kim KB; Cha KS; Oh SK; Chae JK;
Heart Lung Circ; 2021 Apr; 30(4):481-488. PubMed ID: 33012675
[TBL] [Abstract][Full Text] [Related]
48. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
[TBL] [Abstract][Full Text] [Related]
49. Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials.
Sacre JW; Magliano DJ; Shaw JE
Diabetes Care; 2020 Oct; 43(10):2614-2623. PubMed ID: 32958618
[TBL] [Abstract][Full Text] [Related]
50. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
51. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
[TBL] [Abstract][Full Text] [Related]
52. Obesity paradox in patients with hypertension and coronary artery disease.
Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
[TBL] [Abstract][Full Text] [Related]
53. Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study.
Lim YM; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Mayo Clin Proc; 2019 Feb; 94(2):225-235. PubMed ID: 30711120
[TBL] [Abstract][Full Text] [Related]
54. Effect of Body Mass Index on Clinical Events After Acute Coronary Syndromes.
Lamelas P; Schwalm JD; Quazi I; Mehta S; Devereaux PJ; Jolly S; Yusuf S
Am J Cardiol; 2017 Nov; 120(9):1453-1459. PubMed ID: 28916239
[TBL] [Abstract][Full Text] [Related]
55. Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.
Elharram M; Sharma A; White W; Bakris G; Rossignol P; Mehta C; Ferreira JP; Zannad F
Am Heart J; 2020 Nov; 229():40-51. PubMed ID: 32916607
[TBL] [Abstract][Full Text] [Related]
56. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
[TBL] [Abstract][Full Text] [Related]
57. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes.
Marso SP; Mercado N; Maehara A; Weisz G; Mintz GS; McPherson J; Schiele F; Dudek D; Fahy M; Xu K; Lansky A; Templin B; Zhang Z; de Bruyne B; Serruys PW; Stone GW
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S42-52. PubMed ID: 22421230
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial.
Fanola CL; Morrow DA; Cannon CP; Jarolim P; Lukas MA; Bode C; Hochman JS; Goodrich EL; Braunwald E; O'Donoghue ML
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066436
[TBL] [Abstract][Full Text] [Related]
59. The prevalence and outcome of excess body weight among Middle Eastern patients presenting with acute coronary syndrome.
Hadi HA; Zubaid M; Al Mahmeed W; El-Menyar AA; Alsheikh-Ali AA; Singh R; Al-Nabti A; Assad N; Sulaiman K; Al-Mallah MH; Amin H; Al-Motarreb A; Mahmoud H; Al Suwaidi J
Angiology; 2010 Jul; 61(5):456-64. PubMed ID: 20034957
[TBL] [Abstract][Full Text] [Related]
60. Association between the ratio of serum n-3 to n-6 polyunsaturated fatty acids and acute coronary syndrome in non-obese patients with coronary risk factor: a multicenter cross-sectional study.
Nishizaki Y; Shimada K; Tani S; Ogawa T; Ando J; Takahashi M; Yamamoto M; Shinozaki T; Miyazaki T; Miyauchi K; Nagao K; Hirayama A; Yoshimura M; Komuro I; Nagai R; Daida H
BMC Cardiovasc Disord; 2020 Apr; 20(1):160. PubMed ID: 32252654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
